Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.725 | -2.18% | 32.55 | 55,652 | 08:16:40 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 32.50 | 33.85 | 33.05 | 32.55 | 33.05 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 3.1M | -6.51M | -0.0215 | -15.14 | 100.62M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 08:26:28 | O | 540 | 33.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/11/2024 | 07:00 | UK RNS | Futura Medical PLC TR-1: Notification of major holdings |
| 04/11/2024 | 10:57 | ALNC |  Futura Medical progresses study of female sexual dysfunction treatment |
| 04/11/2024 | 07:00 | UK RNS | Futura Medical PLC Encouraging New Product Development Pipeline |
| 31/10/2024 | 07:00 | UK RNS | Futura Medical PLC Total Voting Rights |
| 17/10/2024 | 13:00 | UK RNS | Futura Medical PLC Clinical trial data presented at SMSNA |
| 07/10/2024 | 10:06 | ALNC | IN BRIEF: Futura Medical US pre-orders trigger milestone payment |
| 07/10/2024 | 06:00 | UK RNS | Futura Medical PLC Further milestone payment triggered post US launch |
| 01/10/2024 | 06:00 | UK RNS | Futura Medical PLC Total Voting Rights |
| 13/9/2024 | 06:00 | UK RNS | Futura Medical PLC Directors’ / PDMR Dealing |
| 11/9/2024 | 17:48 | ALNC | *Futura confirms consensus revenue forecast of GBP13.4m for FY24 and.. |
Futura Medical (FUM) Share Charts1 Year Futura Medical Chart |
|
1 Month Futura Medical Chart |
Intraday Futura Medical Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 19/11/2024 | 13:54 | FUTURA a winner for 2015 | 21,879 |
| 07/10/2024 | 06:46 | fum value | 5 |
| 05/6/2024 | 18:50 | Berenberg upgrading Haleon | - |
| 30/5/2024 | 09:36 | FUM this ones bound to rise! | 94 |
| 02/7/2023 | 09:15 | Quiet on here | 34 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 08:26:29 | 33.00 | 540 | 178.20 | O |
| 08:22:32 | 33.00 | 2,287 | 754.71 | O |
| 08:15:56 | 32.55 | 10,559 | 3,436.95 | AT |
| 08:06:21 | 33.00 | 13,000 | 4,290.00 | AT |
| 08:06:18 | 33.05 | 10,627 | 3,512.22 | AT |
| Top Posts |
|---|
Posted at 21/11/2024 08:20 by Futura Medical Daily Update Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 33.28p.Futura Medical currently has 302,403,003 shares in issue. The market capitalisation of Futura Medical is £98,432,177. Futura Medical has a price to earnings ratio (PE ratio) of -15.14. This morning FUM shares opened at 33.05p |
Posted at 16/11/2024 13:13 by petroc Why did you sell your shares in FUM just after the condoms failed and the price had crashed? You lost more than you could afford to lose, and here you are, years later, bitterly bashing the stock out of childish revenge. Ever heard of moving on?On the other hand, LO sold a tiny portion of theirs as a business decision, not because they had to. They've also been doing that for years. |
Posted at 08/11/2024 07:53 by m_night10 POLX Polarean Imaging about to break out above 2p soon. Mcap only $25mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.65p and gap at over 3p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations.Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target imv. DYOR, not advice. |
Posted at 04/11/2024 07:45 by ajmace Two new products should provide a fillip to the FUM share price |
Posted at 11/9/2024 18:30 by keifer derrin I've been in this share for over 5 years and Trinty have been saying the shares are worth a quid and increasing it very year...but here we are the share price of 38p.......which hasn't gone over 68p in all those years.....so either Trinty are rubbish or the market is rigged........I know which one I believe and it's not the latter.......but very happy to be proved wrong....but i wont be holding my breath |
Posted at 10/9/2024 14:43 by mdi And still the share price falls but everything is supposedly so positive and apparently everything going so well. |
Posted at 04/9/2024 17:25 by mdi Glavey and apparently sales are still flying? Again as you say or ‘so BB chatter would have us believe’. But an undisputed fact is FY 2023 results clearly showed Eroxon sales declined in the UK and Belgium in H2 versus H1. Even though everyone kept saying it was the ‘top 5 best selling product’ on Boots, Amazon etc etc. Just like ‘BB chatter’ said was happening at one time with Epic sales supposedly flying on Amazon. But it definitely doesn’t have any sales now and no sign of it anywhere on any best selling lists on Amazon or ever coming back.And oddly enough the share price has again even closed lower today then when similar ‘BB chatter on how well Eroxon was supposedly doing according to some crude online checks which seems to be posted regularly. Seems its be proven now beyond a doubt by the actual 2023 results relying on such ‘BB chatter’ on supposed best seller claims is yet another thing that is definitely ‘pointlessReyeofthetiger - 08 Jan 2024 - 08:30:14 - 20045 of 21589 Eroxon is a game changer product that rivals Viagra without having to pop a pill. Results are due in the weeks ahead and you only need to visit the Boots website to see that the product is flying off the shelves. Take a look at the online store and one can see It has recently been promoted and marketed as a top 5 best selling product for Boots! I think investors are finally going to see the pot of gold they have been waiting for.....(waiting for years might i add). Review the historic highs and we were significantly higher during clinical trials. Eroxon is now a fully commercial product and the upside potential is vast especially from these lows. Mark this message because I think we are going to see a strong rise in the weeks ahead. I mean 3-5x current share price |
Posted at 04/9/2024 13:11 by glavey " it would make anyone wonder why the share price is not still rising? "It does appear that there's stock being dripped into the market but the seller must be disappointed at the lack of volume given that one might think that the confirmation of the timing of the US release was news 'the market' was waiting for (so BB chatter would have us believe). |
Posted at 04/9/2024 12:51 by mdi Marty as far as I am aware no direct blind efficacy comparison study against any similar placebo non medicated hydroalcoholic gel has ever been carried out. A study versus vicks couldn’t be blinded based on odour and perhaps consistency but others in the lubricant industry will understand why you referenced it and why they already sell and market lubricants and arousal gels with menthol. Which are also class 2a medical devices. Maybe some in the industry will now based on the ‘Eroxon’ ‘least burdensome’ medical device path seek to get them reclassified as class 2b and and also cleared as ‘clinically proven’ placebos that also have effects on men with psychological ED.And in reference to: ‘The discussion here is pointless FUM are retailing it, men are buying it’ Didn’t others previously highlight the same being said before about EPIC? Where is that product now? superg1 - 27 Jan 2014 - 07:23:44 - 9314 of 11722 Well it reads well re the launch in stores throughout the US and online. It will obvious who they have launched with once it's for sale, but I would imagine that will mean another rns when it launches anyway stating who it is. Interesting that Ansell will be promoting it individually and as a package. Green Web sold out in quick time so it will be interesting to see how well it goes on a full launch. superg1 - 21 Jan 2014 - 19:22:44 - 9300 of 11722 A post on iii today. Some will know what it is all about After contacting Green web the Amazon the retailers of PET500 I have been told that they "bought every available unit offered by the suppliers". They are keen to get more stock. I made no pretence as to my identity although avoided mentioning I was a FUM investor in my enquiries and simply asked why it was no longer being offered and why the online reviews were allocated. I was asked " Do you work for Ansell? We are extremely interested in continuing to carry the EPIC spray product." I believe the major U.S. retailers Amazon and others are competing to offer the product for the follow-on 'major' launch. I always try to manage my own expectations and therefore had assigned EPIC as a useful peripheral product in terms of driving revenues. I think there are signs that EPIC could turn out to be a more than 'useful' revenue generator for FUM. Looks like punters are desperate for the product, one on ebay apparently sold for $419 (from iii) hxxps://www.ebay.com loobrush - 13 May 2014 - 14:01:03 - 9696 of 11722 EPIC spray out of stock at AMAZON-is it all sold out? Weildy2 - 14 May 2014 - 17:47:44 - 9709 of 11722 OK Guys, here is my take on the FUM AGM yesterday. PET sales launched at 850 Walmart stores three weeks ago and should be available on line by the end of this week. Although it is far too soon to report sales figures, it has been selling in larger quantities than anticipated. Ansell are negotiating with other retailers. Will be sold through Walgreen (the US equivalent of Boots Chemist) which tOpgrader estimates to be approximately 870 stores. |
Posted at 10/6/2024 14:29 by takeiteasy The company share price you are comparing FUM that you are using to beat up FUM has yet to make any sales - it is a development pharma in research validation phases - using a totally different technology so we have zero idea what sales are possible at this stage. Do try to provide better context etc etc. |
Posted at 04/5/2024 15:53 by mdi How much has the Futura market cap declined now since June of last year? I read that the major shareholders average price is still well below even the current share price. So even even if the share price declines further they will still be in profit. So will Directors on many of their 7p and 15p share options if the share price even falls another 40% to the low 20’s. That would still be a Market Cap of nearly £70mHard to tell which is falling faster now. Eroxon sales after the hype or the Futura market cap after the hype. But the fact remains that the £1.7m revenue in April/May was followed by only £1.4m in the following 6 months. New market launches being hyped and staggered may well help short term to prop up the obvious declining sales. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
